Insider Ownership Activity for Scott D. Sandell

SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.

Linked issuers

23

Largest position

Monte Rosa Therapeutics, Inc.

Disclosed value

$411.93M

Transaction activity

Available

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Reporting-owner positions (Forms 3/4/5)

Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.

Estimated position value

3/4/5
$411.93M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Linked issuers

3/4/5
23

Distinct issuers connected to this reporting owner in parsed SEC filings.

Latest parsed filing

SEC
12 Mar 2026

Most recent reporting-owner filing date in the parsed SEC record.

+17 more

Additional issuer positions are listed below.

How to read Forms 3/4/5 positions
  • Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
  • Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Timonium, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Zachary Bambach, attorney-in-fact
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Follow Filing Activity

Follow Scott D. Sandell and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Reported issuer positions for Scott D. Sandell

SVRA Forms 3/4/5

Savara Inc

Relationship
10%+ Owner
Holdings value
$108,897,125
Past year net change
Change %
Report period
17 Jul 2023
COUR Forms 3/4/5

Coursera, Inc.

Relationship
Director
Holdings value
$19,931,213
Past year net change
Change %
Report period
21 May 2025
ARDX Forms 3/4/5

ARDELYX, INC.

Relationship
10%+ Owner
Holdings value
$14,998,764
Past year net change
Change %
Report period
09 Dec 2021
KRRO Forms 3/4/5

Korro Bio, Inc.

Relationship
10%+ Owner
Holdings value
$14,419,591
Past year net change
+$2,300,881
Change %
+19%
Report period
10 Mar 2026
NET Forms 3/4/5

Cloudflare, Inc.

Relationship
Director
Holdings value
$6,767,224
Past year net change
Change %
Report period
05 Jun 2025
CBIO Forms 3/4/5

GLYCOMIMETICS INC

Relationship
10%+ Owner
Holdings value
$5,279,783
Past year net change
Change %
Report period
25 Jan 2023
MTCR Forms 3/4/5

Metacrine, Inc.

Relationship
10%+ Owner
Holdings value
$1,204,731
Past year net change
Change %
Report period
10 Dec 2021
BE Forms 3/4/5

Bloom Energy Corp

Relationship
Director
Holdings value
$684,065
Past year net change
Change %
Report period
31 Mar 2022
IONQ, IONQ-WT Forms 3/4/5

IonQ, Inc.

Relationship
10%+ Owner
Holdings value
$15,076
Past year net change
Change %
Report period
16 Nov 2022
EAR Forms 3/4/5

Eargo, Inc.

Relationship
10%+ Owner
Holdings value
$3,188
Past year net change
Change %
Report period
24 May 2021
AKUS Forms 3/4/5

Akouos, Inc.

Relationship
10%+ Owner
Holdings value
Past year net change
Change %
Report period
30 Nov 2022
ACLX Forms 3/4/5

Arcellx, Inc.

Relationship
10%+ Owner
Holdings value
Past year net change
Change %
Report period
23 Dec 2022

Recent insider transactions for Scott D. Sandell

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .